Press releases

Reaching new heights

Reaching new heights

Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics . . .

January 25, 2019 Origenis GmbH Announces Global License and Collaboration Agreement with Expansion Therapeutics for Novel Therapies...

Origenis Appoints Dr. Peter Seufer-Wasserthal as Chief Business Officer

March 22, 2018 Origenis GmbH, a Germanbiotech company specializing in the discovery and development of highly selective small...

Origenis Announces Patent Grants for Lead Small Molecule LRRK2 Inhibitors for Treatment . . .

May 23, 2017 Worldwide DistributionOrigenis Announces Patent Grants for Lead Small Molecule LRRK2 Inhibitors for Treatment of...